Interestingly, theanti-EBNA1 IgG titre correlated inversely with the frequency of LCL-specificCD8+ T cells, particularly CD8+ EMRA T cells,in the PBMC in the patients with MS (r=−0.18,P=0.0009) (Figure 6d). The gene discussed is CD8A; the disease is myeloid sarcoma.